Hyundai Foundation Strengthens Cancer Care Mission on National Cancer Awareness Day

Gurugram: On National Cancer Awareness Day, Hyundai Motor India Foundation (HMIF), the CSR arm of Hyundai Motor India Limited (HMIL), reaffirmed its commitment to improving cancer care in India through its flagship initiative Hyundai Hope for Cancer, developed in partnership with the Indian Institute of Technology Madras (IIT Madras).

Since its launch in September 2025, the program has made significant progress in cancer research, prevention, and awareness, positively impacting thousands of lives.

At the core of this initiative is the Hyundai Centre for Cancer Genomics at IIT Madras, which houses India’s first community-based Cancer Tissue Biobank and the newly launched Bharat Cancer Genome Atlas (BCGA), the nation’s first open-access cancer genome database aimed at accelerating research and advancing personalised cancer care.

Highlighting Hyundai’s commitment, Mr Puneet Anand, AVP & Vertical Head, Corporate Affairs, Corporate Communication and Social, HMIL, said,

“Hyundai Hope for Cancer represents our belief that technology, compassion and collaboration can bring transformative change in cancer care.

On National Cancer Awareness Day, we renew our dedication to ensuring that every citizen has access to timely, personalised and dignified cancer care.

With an investment of INR 56 crore, including a dedicated INR 3 crore Cancer Care Fund, HMIF aims to expand early detection, research, treatment and community outreach, which have already benefited more than 11,000 people.”

Key Milestones of Hyundai Hope for Cancer

Community Outreach and Screening: A total of 109 cancer awareness and screening camps have been organised across Tamil Nadu, reaching 11,095 individuals.

These included screenings for oral, cervical, colon, breast and prostate cancers. Out of these, 448 individuals tested positive and were referred to government hospitals for advanced treatment.

Cancer Tissue Biobank and Genomic Sequencing:

So far, 1,104 cancer tissue samples have been collected, and whole genome sequencing has been completed for 528 paediatric leukaemia cases.

The ongoing genomic analysis aims to identify India-specific biomarker gene panels to support early diagnosis and better disease tracking.

The launch of the Bharat Cancer Genome Atlas (BCGA) marks a significant step in advancing cancer genomics research in India.

HPV Vaccination Drive:

In collaboration with Karkinos Healthcare and the Cancer Research and Relief Trust (CRRT), 525 girls have been vaccinated against Human Papillomavirus (HPV) across Ariyalur, Virudhunagar and Salem districts in Tamil Nadu.

Upcoming Initiatives

In the coming months, HMIF will provide free cancer treatment for underprivileged children in partnership with leading healthcare institutions across India. It also plans to launch a technician training program to upskill more than 100 laboratory professionals in genomic sequencing and molecular oncology by FY 2026.

A fully equipped Cancer Screening Vehicle has already covered 17 districts in Tamil Nadu, with expansion to Maharashtra and Haryana scheduled for FY 2026.

Over the next four years, HMIF will conduct more than 225 cancer awareness and screening camps across Tamil Nadu, Haryana and Maharashtra, reaching 1.27 lakh people and vaccinating over 5,000 girls against HPV.